New shot could help control breast cancer in younger women
NCT ID NCT06449027
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new injectable form of leuprolide in 211 premenopausal women with hormone-positive breast cancer. The goal is to see if it can safely keep estrogen at postmenopausal levels for nearly a year, which helps control cancer growth. Participants receive the drug and are monitored for hormone levels and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China